GPMET-1

Customer Review 0
5/5

INDICATION & USE

• Reduced risk of hypoglycemia

• Controlling high blood sugar

Share it :

Description

Glimepiride with Metformin Hydrochloride Extended Release Tablets IP

Composition:

Each uncoated bilayered tablet contains :

Metformin Hydrochloride IP 500 mg

(In sustained release form)

Glimepiride IP                            1 mg

Colour: Tartrazine Yellow

INDICATION & USE

• Reduced risk of hypoglycemia

• Controlling high blood sugar

Reviews

There are no reviews yet.

Be the first to review “GPMET-1”

Your email address will not be published. Required fields are marked *